Clinical Trial Update: Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB) [Phase 3]

View source ↗

Summary

Phase 3 INSPIRE-TB trial evaluating an all-oral, shorter, individualized regimen for rifampicin-resistant tuberculosis, including multidrug-resistant and pre-ex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Pre-extensively Drug-resistant Tuberculosis
• Rifampicin-resistant Tuberculosis

Snippet

Sponsor: Huashan Hospital | Conditions: Multidrug Resistant Tuberculosis, Rifampicin Resistant Tuberculosis | Phase 3 | Status: RECRUITING